Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 4
2014 1
2015 2
2016 2
2017 2
2018 1
2020 1
2021 4
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Mesothelioma treatment: Are we on target? A review.
Hiddinga BI, Rolfo C, van Meerbeeck JP. Hiddinga BI, et al. J Adv Res. 2015 May;6(3):319-30. doi: 10.1016/j.jare.2014.11.012. Epub 2014 Dec 1. J Adv Res. 2015. PMID: 26257929 Free PMC article. Review.
Recent developments in the treatment of small cell lung cancer.
Hiddinga BI, Raskin J, Janssens A, Pauwels P, Van Meerbeeck JP. Hiddinga BI, et al. Eur Respir Rev. 2021 Jul 13;30(161):210079. doi: 10.1183/16000617.0079-2021. Print 2021 Sep 30. Eur Respir Rev. 2021. PMID: 34261744 Free PMC article. Review.
Surgery in mesothelioma--where do we go after MARS?
Hiddinga BI, van Meerbeeck JP. Hiddinga BI, et al. J Thorac Oncol. 2013 May;8(5):525-9. doi: 10.1097/JTO.0b013e31828353d7. J Thorac Oncol. 2013. PMID: 23407570 Free article. Review.
High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial.
Zwierenga F, van Veggel B, Hendriks LEL, Hiltermann TJN, Hiddinga BI, Hijmering Kappelle LBM, Ter Elst A, Hashemi SMS, Dingemans AC, van der Leest C, de Langen AJ, van den Heuvel MM, van der Wekken AJ. Zwierenga F, et al. Among authors: hiddinga bi. Lung Cancer. 2022 Aug;170:133-140. doi: 10.1016/j.lungcan.2022.06.012. Epub 2022 Jun 23. Lung Cancer. 2022. PMID: 35777160 Free article. Clinical Trial.
Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature.
Koopman B, Groen HJM, Schuuring E, Hiltermann TJN, Timens W, den Dunnen WFA, van den Berg A, Ter Elst A, van Kruchten M, Kluiver JL, Hiddinga BI, Hijmering-Kappelle LBM, Groves MR, Vilacha JF, van Kempen LC, van der Wekken AJ. Koopman B, et al. Among authors: hiddinga bi. Clin Lung Cancer. 2022 Mar;23(2):e104-e115. doi: 10.1016/j.cllc.2021.06.011. Epub 2021 Jul 3. Clin Lung Cancer. 2022. PMID: 34325996 Free article. Review.
20 results